Suzuki, T., Mizoshita, T., Sugiyama, T., Hirata, Y., Kimura, Y., Suzuki, Y., . . . Sasaki, M. (2019). Adalimumab Dose-Escalation Therapy Is Effective in Refractory Crohn's Disease Patients with Loss of Response to Adalimumab, Especially in Cases without Previous Infliximab Treatment. Case Rep Gastroenterol.
Citação norma ChicagoSuzuki, Taketo, et al. "Adalimumab Dose-Escalation Therapy Is Effective in Refractory Crohn's Disease Patients With Loss of Response to Adalimumab, Especially in Cases Without Previous Infliximab Treatment." Case Rep Gastroenterol 2019.
Citação norma MLASuzuki, Taketo, et al. "Adalimumab Dose-Escalation Therapy Is Effective in Refractory Crohn's Disease Patients With Loss of Response to Adalimumab, Especially in Cases Without Previous Infliximab Treatment." Case Rep Gastroenterol 2019.